12
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Regulatory T Cells: Barriers of Immune Infiltration Into the Tumor Microenvironment

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Regulatory T cells (T regs) are key immunosuppressive cells that promote tumor growth by hindering the effector immune response. T regs utilize multiple suppressive mechanisms to inhibit pro-inflammatory responses within the tumor microenvironment (TME) by inhibition of effector function and immune cell migration, secretion of inhibitory cytokines, metabolic disruption and promotion of metastasis. In turn, T regs are being targeted in the clinic either alone or in combination with other immunotherapies, in efforts to overcome the immunosuppressive TME and increase anti-tumor effects. However, it is now appreciated that T regs not only suppress cells intratumorally via direct engagement, but also serve as key interactors in the peritumor, stroma, vasculature and lymphatics to limit anti-tumor immune responses prior to tumor infiltration. We will review the suppressive mechanisms that T regs utilize to alter immune and non-immune cells outside and within the TME and discuss how these mechanisms collectively allow T regs to create and promote a physical and biological barrier, resulting in an immune-excluded or limited tumor microenvironment.

          Related collections

          Most cited references123

          • Record: found
          • Abstract: found
          • Article: not found

          The diverse functions of the PD1 inhibitory pathway

          T cell activation is a highly regulated process involving peptide-MHC engagement of the T cell receptor and positive costimulatory signals. Upon activation, coinhibitory 'checkpoints', including programmed cell death protein 1 (PD1), become induced to regulate T cells. PD1 has an essential role in balancing protective immunity and immunopathology, homeostasis and tolerance. However, during responses to chronic pathogens and tumours, PD1 expression can limit protective immunity. Recently developed PD1 pathway inhibitors have revolutionized cancer treatment for some patients, but the majority of patients do not show complete responses, and adverse events have been noted. This Review discusses the diverse roles of the PD1 pathway in regulating immune responses and how this knowledge can improve cancer immunotherapy as well as restore and/or maintain tolerance during autoimmunity and transplantation.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            T cell exclusion, immune privilege, and the tumor microenvironment.

            Effective immunotherapy promotes the killing of cancer cells by cytotoxic T cells. This requires not only that cancer-specific T cells be generated, but also that these T cells physically contact cancer cells. The coexistence in some patients of cancer cells and T cells that recognize them indicates that tumors may exhibit the phenomenon of immune privilege, in which immunogenic tissue is protected from immune attack. Here, we review the evidence that stromal cells of the tumor microenvironment mediate this restriction by excluding T cells from the vicinity of cancer cells. Overcoming this T cell checkpoint may thus enable optimal immunotherapy.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Control of regulatory T cell development by the transcription factor Foxp3.

              Regulatory T cells engage in the maintenance of immunological self-tolerance by actively suppressing self-reactive lymphocytes. Little is known, however, about the molecular mechanism of their development. Here we show that Foxp3, which encodes a transcription factor that is genetically defective in an autoimmune and inflammatory syndrome in humans and mice, is specifically expressed in naturally arising CD4+ regulatory T cells. Furthermore, retroviral gene transfer of Foxp3 converts naïve T cells toward a regulatory T cell phenotype similar to that of naturally occurring CD4+ regulatory T cells. Thus, Foxp3 is a key regulatory gene for the development of regulatory T cells.
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Immunol
                Front Immunol
                Front. Immunol.
                Frontiers in Immunology
                Frontiers Media S.A.
                1664-3224
                10 June 2021
                2021
                : 12
                : 702726
                Affiliations
                [1] 1 Department of Immunology, University of Pittsburgh School of Medicine , Pittsburgh, PA, United States
                [2] 2 Tumor Microenvironment Center, University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center , Pittsburgh, PA, United States
                [3] 3 Graduate Program of Microbiology and Immunology, University of Pittsburgh School of Medicine , Pittsburgh, PA, United States
                [4] 4 Cancer Immunology and Immunotherapy Program, UPMC Hillman Cancer Center , Pittsburgh, PA, United States
                Author notes

                Edited by: Rieneke Van De Ven, VU University Medical Center, Netherlands

                Reviewed by: Peter J. Siska, University Medical Center Regensburg, Germany; Eyad Elkord, University of Salford, United Kingdom

                *Correspondence: Dario A. A. Vignali, dvignali@ 123456pitt.edu

                This article was submitted to Cancer Immunity and Immunotherapy, a section of the journal Frontiers in Immunology

                †These authors have contributed equally to this work and share first authorship

                Article
                10.3389/fimmu.2021.702726
                8222776
                34177968
                f14a0e54-4ed0-4779-93a9-0879ac4644f4
                Copyright © 2021 Scott, Gocher, Workman and Vignali

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 29 April 2021
                : 27 May 2021
                Page count
                Figures: 1, Tables: 0, Equations: 0, References: 123, Pages: 10, Words: 4507
                Funding
                Funded by: National Institutes of Health 10.13039/100000002
                Award ID: F32 CA247004, T32 CA082084 , P01 AI108545, R01 CA203689 , P30 CA047904
                Categories
                Immunology
                Mini Review

                Immunology
                regulatory t cells (treg),immune infiltration,tumor microenvironment,cancer,vasculature,stroma

                Comments

                Comment on this article